The document provides data on HIV testing services, treatment, viral load, retention, prevention, and voluntary medical male circumcision (VMMC) from Mwinilunga District Hospital in Zambia from November 2023 to January 2024. It includes tables and charts showing metrics such as the number of people tested and started on treatment, viral load suppression rates, treatment retention, cervical cancer screening rates, and the number of VMMCs performed. The data is from USAID programs in Zambia supported by PEPFAR and intended to monitor progress toward testing and treatment targets.

1. USAID Zambia Integrated Health
MWINILUNGA DISTRICT HOSPITAL
DA
T
AREVIEWMEETINGPRESENT
A
TION
NOVERMBER- JANUARY 2024
DISCLAIMER
This document is made possible by the generous support of the American People through the United States Agency for International Development (USAID) and with support
from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through USAID. The contents of this document are the sole responsibility of Pact and do not necessarily
reflect the views of USAID, PEPFAR, or the United States Government.

2. DATA SET
HTS

3. OTHER PICT VMMC INDEX VCT ANC RETEST ANC TOTAL
TOTAL TESTED 431 42 23 70 150 108 824
TOTAL TESTED POSITIVE 7 0 3 5 1 1 17
POSITIVITY RATE 2% 0% 13% 7% 1% 1% 2%
431
42
23
70
150
108
824
7 0 3 5 1 1 17
2%
0%
13%
7%
1% 1%
2%
0%
2%
4%
6%
8%
10%
12%
14%
0
100
200
300
400
500
600
700
800
900
FIRST 95
HIV TESTING SERVICES
TOTAL TESTED TOTAL TESTED POSITIVE POSITIVITY RATE

4. 918
549
824
30 19 17
3%
3%
2%
0%
1%
1%
2%
2%
3%
3%
4%
4%
0
100
200
300
400
500
600
700
800
900
1000
Nov-23 Dec-23 Jan-24
Nov-23 Dec-23 Jan-24
TOTAL TESTED 918 549 824
TOTAL TESTED POSITIVE 30 19 17
POSITIVITY RATE 3% 3% 2%
FIRST 95
HIV TESTING SERVICES
TOTAL TESTED TOTAL TESTED POSITIVE POSITIVITY RATE

5. 918
549
824
91
21 23
10%
4%
3%
0%
2%
4%
6%
8%
10%
12%
0
100
200
300
400
500
600
700
800
900
1000
45231 45261 45292
Nov-23 Dec-23 Jan-24
TOTAL TESTED 918 549 824
TESTED FROM INDEX 91 21 23
PROPORTION 10% 4% 3%
FIRST 95-PROPORTION OF INDEX TESTING
TOTAL TESTED TESTED FROM INDEX PROPORTION

6. 30
19
18
8
6
3
27%
32%
17%
0%
5%
10%
15%
20%
25%
30%
35%
0
5
10
15
20
25
30
35
Nov-23 Dec-23 Jan-24
Nov-23 Dec-23 Jan-24
TOTAL TESTED POSITIVE 30 19 18
TESTED POSITIVE FROM INDEX 8 6 3
PROPORTION RATE 27% 32% 17%
FIRST 95
PROPORTION OF HIV POSITIVES FROM INDEX TESTING
TOTAL TESTED POSITIVE TESTED POSITIVE FROM INDEX PROPORTION RATE

7. TREATEMENT

8. INDEX ANC ANC RETEST PITC VCT TOTAL
TOTAL TESTED POSITIVE 3 1 1 8 5 18
INITIATED ON ART 3 1 1 8 5 18
LINKAGE RATE 100% 100% 100% 100% 100% 100%
3
1 1
8
5
18
3
1 1
8
5
18
100% 100% 100% 100% 100% 100%
0%
20%
40%
60%
80%
100%
120%
0
2
4
6
8
10
12
14
16
18
20
SECOND 95
LINKAGE TO TREATMENT
TOTAL TESTED POSITIVE INITIATED ON ART LINKAGE RATE

9. EID

10. EID CASCADE
INFANTS TESTED
INFECTE
D
INITIATED ON
ART
MOTHERS STATUST DURING ANC IF
INFANT INFECTED
# OF HEIS BORN 2 2 1 1 DEFAULTED
DUE FOR TEST 0-12 MONTHS 13 13 0 0 NA
DUE FOR TEST AT 24 MONTHS 3 0 0 0 NA

11. VL CASCADE

12. 1278
1239 1239
1062 1079
1043
83%
87%
84%
81%
82%
83%
84%
85%
86%
87%
88%
0
200
400
600
800
1000
1200
1400
Nov-23 Dec-23 Jan-24
Nov-23 Dec-23 Jan-24
TOTAL NUMBER OF CLIENT ELIGIBLE FOR VL 1278 1239 1239
TOTAL NUMBER OF CLIENTS WITH VL 1062 1079 1043
COVERAGE 83% 87% 84%
THIRD 95-GENERAL FACILITY VIRAL LOAD, COVERAGE
TOTAL NUMBER OF CLIENT ELIGIBLE FOR VL TOTAL NUMBER OF CLIENTS WITH VL COVERAGE

13. 83 83
97
78 80
95
94%
96% 96%
93%
93%
94%
94%
95%
95%
96%
96%
97%
0
20
40
60
80
100
120
Nov-23 Dec-23 Jan-24
Nov-23 Dec-23 Jan-24
TOTAL VIRAL LOAD DONE(0-14) 83 83 97
TOTAL SUPPRESSED VIRAL LOAD 78 80 95
SUPPRESSION RATE 94% 96% 96%
THIRD 95 PREGNANT AND BREAST FEEDING VL AND
SUPPRESSION
TOTAL VIRAL LOAD DONE(0-14) TOTAL SUPPRESSED VIRAL LOAD SUPPRESSION RATE

14. 66
63 64
56
52
49
53
51
49
46
47
48
49
50
51
52
53
54
55
0
10
20
30
40
50
60
70
Nov-23 Dec-23 Jan-24
Nov-23 Dec-23 Jan-24
CLIENTS ELGIBLE FOR VL (0-14) 66 63 64
CLIENTS WITH VL (0-14) 56 52 49
SUPPRESSION RATE 95% 98% 100%
PEADS WITH SUPPRESSED VL 53 51 49
PAEDIATRICT VIL SUPPRESSION
CLIENTS WITH VL (0-14) PEADS WITH SUPPRESSED VL SUPPRESSION RATE

15. RETENTION

16. Jan 24 Trend Analysis
Tx_CUUR Dec 1473
IITs 63
Tos 14%
Deaths 1
TX_RRT 52
TX_NEW 18
Tis 10
Jan Tx_Curr 1475
1473
63 14% 1 52 18 10
1475
0
200
400
600
800
1000
1200
1400
1600
RETENTION
Tx_CUUR Dec IITs Tos Deaths TX_RRT TX_NEW Tis Jan Tx_Curr

17. 1479
1473
1475
1470
1471
1472
1473
1474
1475
1476
1477
1478
1479
1480
Nov-23 Dec-23 Jan-24
RECENT TX CURR TREND
TX-CURR

18. MMD 6+, 1166,
79%
MMD 3-5, 247, 17%
MMD 1-2, 62, 4%
TX CURR (1475) COMPOSITION BY MMD TYPE

19. PREVENTION

20. 811
346
43%
0 100 200 300 400 500 600 700 800 900
Jan-24
Jan-24
Screening coverage 43%
Screened for Cacx 346
TX_Curr women 15-49 811
Cervical cancer
Screening coverage Screened for Cacx

21. 1263
1368
1414
1150
1200
1250
1300
1350
1400
1450
Aug-23 Sep-23 Oct-23
RECENT TX CURR TREND
TX-CURR
1475
230
16%
1364
0 200 400 600 800 1000 1200 1400 1600
Jan-24
Jan-24
Clients given TPT 1364
Data entry coverage 16%
TPT in SC 230
Tx Curr 1475
TPT
Clients given TPT Data entry coverage TPT in SC

22. 42
, 0
0
5
10
15
20
25
30
35
40
45
45292
VMMC
VMMC Done Screened for HTS and Tested Testing rate in VMMC

23. ThankYou
Pamex